Hofer S O P, Mitchell G M, Penington A J, Morrison W A, RomeoMeeuw R, Keramidaris E, Palmer J, Knight K R
Bernard O'Brien Institute of Microsurgery and University of Melbourne, Department of Surgery at St Vincent's Hospital, Melbourne, Fitzroy, Vic. 3065, Australia.
Br J Plast Surg. 2005 Dec;58(8):1104-14. doi: 10.1016/j.bjps.2005.04.033. Epub 2005 Jul 25.
The distribution of hypoxic cells in an in vivo tissue engineering chamber was investigated up to 28 days post-implantation.
Arteriovenous loops were constructed and placed into bi-valved polycarbonate chambers containing 2 x 10(6) rat fibroblasts in basement membrane gel (BM gel). Chambers were inserted subcutaneously in the groin of male rats and harvested at 3 (n = 6), 7 (n = 6), 14 (n = 4) or 28 (n = 4) days. Ninety minutes before harvest, pimonidazole (60 mg/kg) was injected intraperitoneally. Chamber tissue was removed, immersion fixed, paraffin embedded, sectioned and stained immunohistochemically using hypoxyprobe-1 Mab that detects reduced pimonidazole adducts forming in cells, where pO2 < 10 mmHg.
At 3 days a fibrin clot/BM gel framework filled the chamber. Seeded fibroblasts had largely died. The majority of 3 day chambers did not demonstrate tissue growth from the AV loop nor was pimonidazole binding present in these chambers. In one chamber in which tissue growth had occurred strong pimonidazole binding was evident within the new tissue. In four out of six 7 day chambers a broader proliferative zone existed extending up to 0.4 mm (approximately) from the AV loop endothelium which demonstrated intense pimonidazole binding. The two remaining 7 day chambers displayed even greater tissue growth (leading edge > 0.7 mm from the AV loop endothelium), but very weak or no pimonidazole binding. At 14 and 28 days the fibrin/BM gel matrix was replaced by mature vascularised connective tissue that did not bind pimonidazole.
Employing a tissue engineering chamber, new tissue growth extending up to 0.4 mm from the AV loop endothelium (chambers < or = 7 days) demonstrated intense pimonidazole binding and, therefore, hypoxia. Tissue growth greater than 0.5 mm from the AV loop endothelium (7-28 days chambers) did not exhibit pimonidazole binding due to a significant increase in the number of new blood vessels and was, therefore, adequately oxygenated.
研究了体内组织工程腔室中缺氧细胞在植入后长达28天的分布情况。
构建动静脉环,并将其置于含有2×10⁶大鼠成纤维细胞的双瓣聚碳酸酯腔室中,细胞位于基底膜凝胶(BM凝胶)中。将腔室皮下植入雄性大鼠腹股沟,分别在3天(n = 6)、7天(n = 6)、14天(n = 4)或28天(n = 4)时收获。在收获前90分钟,腹腔注射匹莫硝唑(60 mg/kg)。取出腔室组织,进行浸固定、石蜡包埋、切片,并使用Hypoxyprobe-1单克隆抗体进行免疫组织化学染色,该抗体可检测细胞中形成的还原型匹莫硝唑加合物,其中pO₂ < 10 mmHg。
3天时,纤维蛋白凝块/BM凝胶框架充满腔室。接种的成纤维细胞大多已死亡。大多数3天的腔室未显示出动静脉环的组织生长,这些腔室中也不存在匹莫硝唑结合。在一个发生组织生长的腔室中,新组织内明显存在强烈的匹莫硝唑结合。在6个7天的腔室中有4个存在更广泛的增殖区,从动脉静脉环内皮向上延伸至约0.4 mm,显示出强烈的匹莫硝唑结合。其余2个7天的腔室显示出更大的组织生长(前沿距动脉静脉环内皮> 0.7 mm),但匹莫硝唑结合非常弱或无结合。在14天和28天时,纤维蛋白/BM凝胶基质被成熟的血管化结缔组织取代,该组织不结合匹莫硝唑。
使用组织工程腔室,从动脉静脉环内皮向上延伸至0.4 mm的新组织生长(腔室≤7天)显示出强烈的匹莫硝唑结合,因此存在缺氧。距动脉静脉环内皮大于0.5 mm的组织生长(7 - 28天的腔室)由于新血管数量显著增加而未表现出匹莫硝唑结合,因此氧合充足。